BioTelemetry, Inc. (BEAT) News
Filter BEAT News Items
BEAT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BEAT News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BEAT News From Around the Web
Below are the latest news stories about HEARTBEAM INC that investors may wish to consider to help them evaluate BEAT as an investment opportunity.
HeartBeam to Attend JP Morgan 2025 Annual Healthcare ConferenceSANTA CLARA, Calif., December 23, 2024--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference |
HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearanceDistinguished by its credit card size and cable-free design, the device is claimed to be the first of its kind to be cleared by the US regulator. |
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring TechnologySANTA CLARA, Calif., December 16, 2024--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology |
HeartBeam And 2 Other US Penny Stocks With Promising PotentialAs the U.S. stock market reaches record highs, driven by strong tech earnings and anticipation of Federal Reserve insights, investors are exploring diverse opportunities across various sectors. Penny stocks, though often associated with speculative trading, remain a compelling area for those seeking potential value in smaller or newer companies. By focusing on penny stocks with robust financials and growth potential, investors can uncover promising opportunities that might otherwise go... |
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association ConferenceSANTA CLARA, Calif., November 19, 2024--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference |
HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology. |
HeartBeam Reports Third Quarter 2024 ResultsSANTA CLARA, Calif., November 07, 2024--HeartBeam Reports Third Quarter 2024 Results |
Spotlight On US Penny Stocks In October 2024As the U.S. stock market experiences a downturn, particularly impacting major tech companies, investors are reassessing their strategies amid fluctuating earnings reports and economic indicators. In this climate of uncertainty, penny stocks—though often overlooked—continue to present intriguing opportunities for growth, especially when they boast solid financial health. These smaller or newer companies can offer unique value and growth prospects that larger firms might miss, making them an... |
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern TimeSANTA CLARA, Calif., October 31, 2024--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time |
HeartBeam, Inc. (BEAT): A Bull Case TheoryWe came across a bullish thesis on HeartBeam, Inc. (BEAT) on Triple S Special Situations Investing’s Substack by TripleS Special Situations. In this article, we will summarize the bulls’ thesis on BEAT. HeartBeam, Inc.’s share was trading at $2.30 as of Oct 24th. HeartBeam, Inc. (NASDAQ:BEAT) is on the brink of potentially transforming cardiac care with its […] |